Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)

Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fresenius Medical Care Ag & CO Kgaa Else-Kroener-Strasse 1 Bad Homburg HE 61352 DEU

P: +49 791033353

Description:

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Key Statistics

Overview:

Market Capitalization, $K 10,460,189
Shares Outstanding, K 293,413
Annual Sales, $ 19,454 M
Annual Net Income, $ 498,997 K
Last Quarter Sales, $ 4,988 M
Last Quarter Net Income, $ 187,925 K
% of Institutional Shareholders 37.80%

Growth:

1-Year Return -8.51%
3-Year Return -39.09%
5-Year Return 0.00%
5-Year Revenue Growth 3.29%
5-Year Earnings Growth -23.41%
5-Year Dividend Growth 1.11%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 1.70
EPS Growth vs. Prev Qtr 120.69%
EPS Growth vs. Prev Year -25.76%
Annual Dividend Rate, $ 1.12
Annual Dividend Yield 3.01%
Most Recent Dividend 1.190 on 05/17/24
Next Ex-Dividends Date 05/17/24
Dividend Payable Date 05/22/24
Dividend Payout Ratio 65.88%
Most Recent Split 3-1 on 06/18/07

FME.D.DX Ratios

Ratio
Price/Earnings ttm 23.29
Price/Earnings forward 12.25
Price/Earnings to Growth 0.46
Return-on-Equity % 3.61%
Return-on-Assets % 1.43%
Profit Margin % 2.57%
Debt/Equity 0.77
Price/Sales 0.60
Price/Cash Flow 4.42
Price/Book 0.85
Book Value/Share 46.42
Interest Coverage 3.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar